PerkinElmer posts growth in Q2

By The Science Advisory Board staff writers

July 26, 2021 -- PerkinElmer posted revenue and operating income increases in its second quarter 2021 (end-July 4).

For the quarter, the company reported revenue in its Discovery and Analytical Solutions segment of $513 million, compared to $391 million for the same period in 2020. It posted operating income from continuing operations for the segment of $64 million, compared to $39 million for the second quarter of last year, and operating income of $101 million, compared to $57 million in the same period in 2020.

In other PerkinElmer news, the company announced that it will acquire antibody and research reagent manufacturer BioLegend for $5.25 billion.


Copyright © 2021 scienceboard.net
 
To access all The ScienceBoard content create a free account now:


Email Address:  

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.


Letter from the Editor Please send me twice-weekly roundups of all the latest life research and industry news.
SAB Announcements Please send me the latest announcements from The Science Advisory Board and their partners.
Spotlight Receive notifications about new content, services, or educational resources designed to help you sharpen your skills and grow professionally.
 
I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.

Already have an account? Sign in here